Zhejiang Shouxiangu Pharmaceutical (603896) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

CN Stock MarketDetailed Quotes

603896 Zhejiang Shouxiangu Pharmaceutical

Watchlist

19.98
+0.07+0.35%

Not Open Jan 16 15:00 CST

3.96BMarket Cap16.95P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

These 4 Measures Indicate That Zhejiang Shouxiangu Pharmaceutical (SHSE:603896) Is Using Debt Extensively
Simply Wall StDec 23, 2024 18:39 ET
Zhejiang Shouxiangu Pharmaceutical (SHSE:603896) Will Be Hoping To Turn Its Returns On Capital Around
Simply Wall StNov 7, 2024 19:00 ET
Shouxiangu Pharmaceutical's Unit Gets Registration Certificate for Food Supplement; Shares Up 4%
MT NewswiresNov 7, 2024 01:03 ET
Retail Investors Invested in Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHSE:603896) Copped the Brunt of Last Week's CN¥474m Market Cap Decline
Simply Wall StOct 14, 2024 20:07 ET
Zhejiang Shouxiangu Pharmaceutical Subsidiary Gets 350-Million-Yuan Construction Contract
MT NewswiresSep 30, 2024 05:01 ET
Zhejiang Shouxiangu Pharmaceutical's (SHSE:603896) Earnings Trajectory Could Turn Positive as the Stock Surges 10% This Past Week
Simply Wall StSep 26, 2024 19:55 ET

Comments

Moomoo AI

Jan 31, 2024 22:32

Zhejiang Shouxiangu Pharmaceutical's low P/E ratio is due to its projected growth being less than the broader market. Investors foresee limited future growth and are only prepared to pay a lower price for the stock, suggesting the share price may not rise significantly soon.

Zhejiang Shouxiangu Pharmaceutical Co., Ltd.'s (SHSE:603896) Prospects Need A Boost To Lift Shares

Moomoo AI

Jan 8, 2024 20:20

Despite recent pullback, Zhejiang Shouxiangu Pharmaceutical's long-term performance remains strong. The market's caution towards the stock, despite higher EPS growth, suggests a potential opportunity amidst the sell-off.

The Total Return for Zhejiang Shouxiangu Pharmaceutical (SHSE:603896) Investors Has Risen Faster Than Earnings Growth Over the Last Five Years

Moomoo AI

Oct 10, 2023 22:42

Zhejiang Shouxiangu Pharmaceutical's strong EPS growth and significant investment by company leaders suggest a promising outlook. The strong financial performance and insider investment align well with shareholder interests, painting the company as a worthy candidate for further investigation.